Novavax Inc. Stock Outperforms Competitors On Strong Trading Day
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Novavax Inc. (NVAX) rallied 3.35% to $11.71 Thursday, on what proved to be an all-around poor trading session for the stock market, with the NASDAQ Composite Index falling 1.47% to 10,305.24 and Dow Jones Industrial Average falling 1.02% to 32,930.08. This was the stock's second consecutive day of gains. Novavax Inc. closed $125.95 below its 52-week high ($137.66), which the company achieved on January 10th.
The stock outperformed some of its competitors Thursday, as Johnson & Johnson (JNJ) fell 0.74% to $178.80, Pfizer Inc. (PFE) fell 0.94% to $49.66, and Merck & Co. Inc. (MRK) rose 1.39% to $113.64. Trading volume (9.2 M) eclipsed its 50-day average volume of 6.4 M.
Data source: Dow Jones Market Data, FactSet. Data compiled Janurary 5, 2023.
(END) Dow Jones Newswires
January 05, 2023 17:15 ET (22:15 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.